Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...

Click to deselect and select. Nov 13, 2025, 12:54 AM IST AvanceTechnologies - Un-Audited Financial Results For The Quarter And Half Year Ended As On 30Th September, 2025. Nov 13, 2025, 12:45 AM IST ...

Avance Technologies Limited is a technology infrastructure ecosystem company. The Company is engaged in designing, constructing and operating some of data center operations in the world. The Company's ...

Maskot Axogen (AXGN) on Wednesday said that the U.S. Food and Drug Administration has approved the biologics license application for AVANCE (acellular nerve allograft-arwx). Avance is an acellular ...

Avance Technologies Limited was formerly known as VMC Software Limited in 1985 and the Company name was changed to Avance Technologies Limited in March 2003. The Company operates in software related ...

Is VMEO a buy now? Chart does not reflect overnight price.

Avance Technologies Q2 Results: Check out Avance Technologies Q2 Result news, Avance Technologies Q2 Earnings result updates and highlights. | Avance Technologies Q2 Results 2025 ...

Wakefit’s IPO opened to a subdued 11% Day 1 subscription, with retail showing moderate interest and institutions staying away. Despite a positive GMP hinting at a premium listing, concerns persist ...